{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:39:09Z","timestamp":1793083149688,"version":"4.5.0"},"reference-count":16,"publisher":"Massachusetts Medical Society","issue":"26","license":[{"start":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T00:00:00Z","timestamp":1545868800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.nejmgroup.org\/legal\/terms-of-use.htm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,12,27]]},"DOI":"10.1056\/nejmoa1810858","type":"journal-article","created":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T10:30:16Z","timestamp":1540117816000},"page":"2495-2505","source":"Crossref","is-referenced-by-count":2658,"title":["Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer"],"prefix":"10.1056","volume":"379","author":[{"given":"Kathleen","family":"Moore","sequence":"first","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung-Gie","family":"Kim","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Oaknin","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Friedlander","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Lisyanskaya","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Floquet","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Leary","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabe S.","family":"Sonke","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlie","family":"Gourley","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Banerjee","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Oza","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonz\u00e1lez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bradley","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Mathews","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Liu","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Lowe","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"DiSilvestro","sequence":"additional","affiliation":[{"name":"From the Stephenson Cancer Center at the University of Oklahoma, Oklahoma City (K.M.); University of Milan\u2013Bicocca, European Institute of Oncology Istituto di Ricovero e Cura a Carattere Scientifico, Milan (N.C.), and Fondazione Policlinico Universitario A. Gemelli IRCCS Universit\u00e0 Cattolica, Rome (G.S.) \u2014 both in Italy; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea (B.-G.K.); Vall d\u2019Hebron University Hospital, Vall d\u2019Hebron Institute of Oncology, Barcelona ..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_5_2_2","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: ovarian cancer version 2. 2018 (https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf)."},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt333"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104390"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103799"},{"key":"e_1_3_5_6_2","doi-asserted-by":"crossref","unstructured":"Burger RA Enserro D Tewari KS et al. Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: a NRG oncology\/Gynecologic Oncology Group (GOG) study. J Clin Oncol 2018;36:5517-5517. abstract.","DOI":"10.1200\/JCO.2018.36.15_suppl.5517"},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.10.040"},{"key":"e_1_3_5_8_2","unstructured":"AstraZeneca. Lynparza (olaparib) tablets for oral use: prescribing information. 2018 (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/208558s001lbl.pdf)."},{"key":"e_1_3_5_9_2","unstructured":"AstraZeneca. Global policy: bioethics. 2016 (https:\/\/www.astrazeneca.com\/content\/dam\/az\/PDF\/2016\/Bioethics_policy.pdf)."},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-1327"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8545"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32440-6"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611310"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30469-2"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.5533"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30376-X"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.10.017"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa1810858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T20:31:56Z","timestamp":1711485116000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1810858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,27]]},"references-count":16,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018,12,27]]}},"alternative-id":["10.1056\/NEJMoa1810858"],"URL":"https:\/\/doi.org\/10.1056\/nejmoa1810858","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,27]]}}}